Healthcare Realty Trust Incorporated (HR) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call presents a positive outlook with strong financial metrics such as 6.9% same-store growth and expanded margins. Despite cautious guidance, the strategic focus on capital allocation, redevelopment, and joint ventures suggests optimism. The Q&A highlights management's disciplined approach and proactive measures, which are well-received by analysts. Positive factors like strong leasing spreads, proactive lease renewals, and no significant tenant move-outs further support a positive sentiment. However, the lack of detailed guidance on acquisitions and asset sales tempers the optimism slightly.
Key Financial Performance
Same-store NOI growth Nearly 7%, an all-time high. This growth is attributed to improved leasing outcomes, higher retention rates, and increased cash leasing spreads.
Same-store occupancy 92.3%, a year-over-year increase of 110 basis points. This improvement is driven by strong demand and limited supply growth in the sector.
Total occupancy 90.5%. This is a significant near-term earnings growth driver as the company stabilizes its lease-up and redevelopment portfolios.
Retention rate 93.5%. Higher retention rates reduce downtime and capital expenditures, leading to more profitable deals.
Cash leasing spreads 4.2%. One out of every four leases signed had a cash leasing spread greater than 5%, reflecting improved portfolio optimization and concentration in higher growth markets.
Annual escalators on signed leases 3% plus. This is a critical driver of core earnings growth, with portfolio NOI at approximately $650 million.
Normalized FFO per share $0.41, up sequentially from $0.40. This increase is driven by higher same-store occupancy, cash leasing spreads, and an improved balance sheet.
FAD per share $0.32, resulting in a quarterly dividend payout ratio of 75%.
Stock buybacks $100 million of stock repurchased year-to-date at a weighted average price of $17.38. This provides significant and immediate accretion.
Joint venture acquisitions $18 million at the company's pro rata share. These acquisitions are expected to yield initial cash returns greater than 7%.
Redevelopment investments $25 million invested in the redevelopment portfolio, which is expected to yield a cash-on-cash return of 10%.
Same-store margins Expanded by 60 basis points year-over-year, reflecting improved operational efficiency.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Leasing Activity: The company signed over 2 million square feet of leases, an all-time high, with a retention rate of 93.5%. This includes significant health system activity in Atlanta, Charlotte, Upstate New York, and Charleston.
Redevelopment Projects: Two new redevelopment projects were initiated, including a $25 million redevelopment in Boston and a $35 million project in Charlotte. These projects are expected to yield 9%-12% stabilized returns.
Earnings Growth: Normalized FFO per share increased to $0.41, and same-store NOI growth reached 6.9%. The company raised its full-year guidance for FFO and same-store NOI growth.
Occupancy: Same-store occupancy improved to 92.3%, a year-over-year increase of 110 basis points. Total occupancy reached 90.5%.
Capital Allocation: The company repurchased $100 million of stock, completed $20 million in acquisitions, and invested $25 million in redevelopment projects.
Portfolio Optimization: The company completed its portfolio optimization and deleveraging efforts, focusing on higher-growth markets and outpatient medical facilities.
Joint Ventures: The company plans to allocate $50 million to $100 million into joint ventures in 2026, targeting initial cash yields of over 7%.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Market Conditions: The company faces challenges due to the current high interest rate environment, with the 10-year treasury at 4.3%, which impacts the attractiveness of their stock trading at an 11x FFO multiple.
Strategic Execution Risks: The company acknowledges the need to break down historical stereotypes in the medical office sector and redefine success, which could pose challenges in execution.
Occupancy and Leasing Risks: While occupancy has improved, total occupancy is still at 90.5%, indicating room for stabilization. Additionally, the company relies on a robust leasing pipeline and retention rates to drive growth, which could be impacted by market dynamics.
Capital Allocation Risks: The company plans to allocate capital towards stock buybacks, joint ventures, and redevelopments, but these priorities are not mutually exclusive, which could lead to resource allocation challenges.
Redevelopment Risks: The redevelopment portfolio, consisting of 23 properties, is 64% pre-leased. There is a risk associated with achieving the projected $50 million NOI upside and completing projects on schedule.
Debt and Liquidity Risks: The company is managing a $600 million bond maturity and plans to use a new $400 million unsecured delayed draw term loan. This reliance on debt markets and interest rate fluctuations could pose financial risks.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Earnings Growth: The company expects core earnings growth in 2026 to track above 5%, excluding the impact from portfolio optimization and deleveraging. Materially higher earnings growth is anticipated due to factors such as occupancy growth, annual escalators, higher retention, and improved cash leasing spreads.
Occupancy: Sector-wide occupancy is approaching 93%, driven by strong demand and limited supply growth. The company’s same-store occupancy improved to 92.3%, with total occupancy at 90.5%. Multiple years of sustained tailwinds are expected due to the growth of the 65-plus population and the shift to outpatient care settings.
Annual Escalators: The average annual escalator on signed leases is 3% or more, which will be a primary driver of core earnings growth going forward.
Retention Rate: The retention rate was 93.5% in Q1, which is expected to remain a critical driver of earnings growth by reducing downtime and capital expenditures.
Cash Leasing Spreads: Cash leasing spreads averaged 4.2% in Q1, with 25% of leases signed having a spread greater than 5%. This is expected to improve further due to portfolio optimization and concentration in higher-growth markets.
Redevelopment Portfolio: The redevelopment portfolio consists of 23 properties, 64% pre-leased, and is expected to contribute $50 million of NOI upside in the 3-year forecast. Redevelopment projects are tracking ahead of schedule, with an average cash-on-cash yield of 10%.
Capital Allocation: The company plans to allocate $50 million to $100 million of capital into joint ventures in 2026, with initial cash yields exceeding 7%. Stock buybacks will continue if dislocation in stock price occurs, with $400 million of buyback capacity remaining. Redevelopment investments will be front-loaded to maximize NOI upside sooner.
Guidance Updates: Full-year normalized FFO per share guidance increased to $1.59 to $1.65, with same-store cash NOI growth revised to 3.75% to 4.75%. Guidance does not include additional acquisitions, redevelopments, or share repurchases for the remainder of the year.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Quarterly Dividend Payout Ratio: 75%
Stock Buybacks in Q1: $100 million of shares repurchased year-to-date, totaling 5.7 million shares at a weighted average price of $17.38
Remaining Stock Buyback Capacity: $400 million under current authorization
Capital Allocation Priorities: Stock buybacks, joint venture acquisitions, and redevelopments are prioritized for accretive growth.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What drove the 6.9% same-store growth in Q1, and is it repeatable?
A:The 6.9% same-store growth in Q1 was driven by a significant ramp-up in occupancy year-over-year, margin improvements, and strong leasing. Management noted that Q1 had easier comps compared to the rest of the year and expects growth to remain strong but not necessarily at the 7% level.
Q:How does management balance capital allocation between buybacks, leverage, and other investments?
A:Management emphasized a disciplined approach to capital allocation, balancing buybacks, JV acquisitions, and redevelopments. They are open to selling core assets to recycle capital into these priorities while maintaining leverage at a manageable level.
Q:What is the timeline for achieving the 92%-93% total occupancy target?
A:The company is currently at 90.5% occupancy and aims to reach 92%-93% over time. A significant portion of the signed-not-occupied (SNO) pipeline, which includes 490,000 square feet in redevelopment, is expected to contribute to occupancy gains this year.
Q:Why is management open to selling core assets, and what is the strategy behind it?
A:Management is open to selling core assets to recycle capital into higher-growth opportunities, such as JVs or redevelopments. They believe this approach can improve the portfolio's long-term growth profile and provide accretive returns.
Q:What is the interest level in outpatient medical JVs, and how is the transaction market performing?
A:Management is focused on growing its JV with KKR, which has shown interest in expanding. The transaction market remains strong, with core assets pricing at 5.5%-6% cap rates and core-plus assets slightly higher.
Q:What are the expectations for lease retention and escalators in the outpatient medical space?
A:Lease retention is expected to stabilize at 80%-85%, up from historical levels of 75%-80%. Cash leasing spreads were over 4% in Q1, with 25% of leases achieving spreads greater than 5%. Management aims to improve these metrics further.
Q:What drove early lease renewals, and will these assets be sold?
A:Early lease renewals were driven by tenant approaches and management's proactive efforts. These renewals extended the weighted average lease term and unlocked value, but management has not disclosed specific plans to sell these assets.
Q:Why does guidance not reflect strong acquisition opportunities?
A:Guidance only includes announced sources and uses of funds. Management remains cautious and does not include future acquisitions or share repurchases in guidance, despite seeing attractive opportunities.
Q:What is the frictional vacancy level for the portfolio, and how high can occupancy go?
A:Frictional vacancy is estimated at mid- to high-single digits. Management aims to achieve 92%-93% occupancy in the same-store portfolio, with total portfolio occupancy also targeted at 92%-93%.
Q:Are there any known tenant move-outs or other factors that could impact NOI growth?
A:No significant tenant move-outs are expected. Retention is projected at 80%-85%, and management anticipates strong same-store NOI growth for the year, despite tougher comps in upcoming quarters.
Q:What is the expected yield on recent acquisitions, and how does it compare to dispositions?
A:Recent acquisitions, such as the Alabama deal, have a year-one yield of over 7%, including JV fees. Dispositions of core assets are expected to achieve cap rates of 5.5%-6%, with core-plus assets slightly higher.
Q:What is the updated outlook on the 3-year strategic plan?
A:The company is tracking ahead of schedule on its 3-year strategic plan, with strong Q1 results exceeding expectations. Management aims to continue executing with intensity to achieve further upside.
Q:Are there signs of supply picking up in the outpatient medical space?
A:No significant increase in supply has been observed. New completions have dropped, and new starts remain below historical averages, tracking at 1% of inventory.
Q:Review of Unclear Management Responses
A:Management avoided directly addressing the specific timeline for achieving the 92%-93% occupancy target, providing only general comments about ongoing efforts and contributions from the SNO pipeline. Additionally, they did not provide detailed plans for the potential sale of early renewed assets or specific growth targets for the JV portfolio.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
AA credit
AI platform
Atlanta MSA
Charlotte
Health health
Health system
MUSC
Medical Center
Trinity Health
WellStar
acquisition portfolio
cash yield
center
completion
credit rating
deal retention
director
driver
escalator lease
front
lease deal
lease foot
lease term
multiple
pillar
portfolio optimization
preparation
project
renewal foot
renewal lease
retention rate
sector
stock buyback
system relationship
term year
treasury
venture acquisition
year cash
HR Transcript
Healthcare Realty Trust Incorporated (HR) Q1 2026 Earnings Call Transcript
Positive5-1
The earnings call presents a positive outlook with strong financial metrics such as 6.9% same-store growth and expanded margins. Despite cautious guidance, the strategic focus on capital allocation, redevelopment, and joint ventures suggests optimism. The Q&A highlights management's disciplined approach and proactive measures, which are well-received by analysts. Positive factors like strong leasing spreads, proactive lease renewals, and no significant tenant move-outs further support a positive sentiment. However, the lack of detailed guidance on acquisitions and asset sales tempers the optimism slightly.
Healthcare Realty Trust Incorporated (HR) Q4 2025 Earnings Call Transcript
Positive2-13
The earnings call highlights strong financial performance, increased occupancy, and strategic capital allocation. The Q&A section reveals positive trends in leasing and redevelopment, with management showing discipline in acquisitions and a focus on shareholder value. Despite some uncertainties in future absorption and JV specifics, the overall sentiment is positive, supported by raised guidance and favorable market conditions.
Healthcare Realty Trust Incorporated (HR) Q3 2025 Earnings Call Transcript
Positive10-31
The earnings call summary highlights strong financial performance with improved NOI guidance and a robust leasing pipeline. Despite a dividend cut, strategic reinvestment in the portfolio is expected to drive future growth. The Q&A section supports this positive outlook, with management providing optimistic guidance on NOI growth and redevelopment projects. However, some concerns about margin improvement timing and general responses were noted. Overall, the positive aspects outweigh the negatives, suggesting a likely stock price increase of 2% to 8% over the next two weeks.
Healthcare Realty Trust Incorporated (HR) Q2 2025 Earnings Call Transcript
Unknown8-1
The earnings call summary provides a mixed outlook. While there is optimism in leasing growth and strategic asset management, concerns remain over underperformance in the lease-up portfolio and uncertainties in macroeconomic factors. The Q&A session reveals management's confidence in operational improvements and cost-cutting, but also highlights challenges in achieving targets and unclear responses to regulatory impacts. The reaffirmed guidance and dividend stability are positive, yet the lack of strong catalysts or partnerships tempers expectations, leading to a neutral sentiment prediction for the stock price movement.
HR Slides
HR Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
